about
Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction.First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension.Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT CellsCirculating C19MC microRNAs in preeclampsia, gestational hypertension, and fetal growth restriction.The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses.Extracellular chromosome 21-derived microRNAs in euploid & aneuploid pregnancies.Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency.Absolute and relative quantification of placenta-specific micrornas in maternal circulation with placental insufficiency-related complications.[Extracellular chromosome 21--derived microRNAs in maternal circulation: evaluation of their diagnostic potential for screening of Down syndrome].[Detection of placenta-specific microRNAs in maternal circulation].Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral bloodAssessment of placental and maternal stress responses in patients with pregnancy related complications via monitoring of heat shock protein mRNA levelsPlacental-specific microRNA in maternal circulation – identification of appropriate pregnancy-associated microRNAs with diagnostic potential
P50
Q30387502-C1CEC6ED-20A1-4518-90BE-D39824DF9763Q34702612-ED2BB88A-8938-407F-B1E2-9FEB86E0946DQ35800606-E4A4AD45-85AE-47ED-B5AF-A61788FFD104Q35959395-04BA09A1-8B91-4739-A7E6-C648925872F8Q37358895-43C17F06-1E97-46CF-94E1-E2BF0DC35160Q37433980-E5CE4AF9-E704-4DB9-86AF-41D594B84EA9Q37690852-04518F93-D3B5-4BC8-9CF2-EF1AAE88A917Q43996404-F76AA3B0-4F60-49A0-84B9-727BB142B299Q46325280-0B75A525-34B6-427B-87D5-F1E87F72E446Q53136305-5A451990-5AC0-4652-8481-6EE4BAB0903BQ54414428-5544DF1E-5FB8-4F49-9C0D-737177F182CFQ60669865-30D91E44-0AF7-4BB6-8E3B-E60E1D90C7BDQ60669873-F4E614CD-A229-4010-AE1C-CDEFFE8D21C6Q60669888-9D5C4677-0D12-47EB-AF10-9B2E0A15F8E6
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Katerina Kotlabova
@ast
Katerina Kotlabova
@en
Katerina Kotlabova
@es
Katerina Kotlabova
@nl
Katerina Kotlabova
@sl
type
label
Katerina Kotlabova
@ast
Katerina Kotlabova
@en
Katerina Kotlabova
@es
Katerina Kotlabova
@nl
Katerina Kotlabova
@sl
prefLabel
Katerina Kotlabova
@ast
Katerina Kotlabova
@en
Katerina Kotlabova
@es
Katerina Kotlabova
@nl
Katerina Kotlabova
@sl
P106
P1153
36453000600
P21
P31
P496
0000-0002-8824-4653